Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients

Q2 Medicine

BMC Clinical Pathology Pub Date : 2015-11-16 DOI:10.1186/s12907-015-0019-z

M. Majores, A. Schindler, A. Fuchs, J. Stein, L. Heukamp, P. Altevogt, G. Kristiansen

引用次数: 16

查看原文本刊更多论文

单克隆抗体SWA11检测的膜CD24表达是非小细胞肺癌患者的预后标志物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Clinical Pathology Medicine-Pathology and Forensic Medicine

CiteScore

3.30

自引率

0.00%

发文量

期刊介绍： BMC Clinical Pathology is an open access journal publishing original peer-reviewed research articles in all aspects of histopathology, haematology, clinical biochemistry, and medical microbiology (including virology, parasitology, and infection control). BMC Clinical Pathology (ISSN 1472-6890) is indexed/tracked/covered by PubMed, CAS, EMBASE, Scopus and Google Scholar.